The Burden of Human African Trypanosomiasis

被引:181
作者
Fevre, Eric M. [1 ]
v. Wissmann, Beatrix [2 ]
Welburn, Susan C. [2 ]
Lutumba, Pascal [3 ,4 ]
机构
[1] Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Coll Med & Vet Med, Ctr Infect Dis, Edinburgh, Midlothian, Scotland
[3] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO
[4] Inst Trop Med, B-2000 Antwerp, Belgium
来源
PLOS NEGLECTED TROPICAL DISEASES | 2008年 / 2卷 / 12期
关键词
D O I
10.1371/journal.pntd.0000333
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Human African trypanosomiasis (HAT, or sleeping sickness) is a protozoan parasitic infection caused by Trypanosoma brucei rhodesiense or Trypanosoma brucei gambiense. These are neglected tropical diseases, and T.b. rhodesiense HAT is a zoonosis. We review current knowledge on the burden of HAT in sub-Saharan Africa, with an emphasis on the disability-adjusted life year (DALY), data sources, and methodological issues relating to the use of this metric for assessing the burden of this disease. We highlight areas where data are lacking to properly quantify the impact of these diseases, mainly relating to quantifying under-reporting and disability associated with infection, and challenge the HAT research community to tackle the neglect in data gathering to enable better evidence-based assessments of burden using DALYs or other appropriate measures.
引用
收藏
页数:7
相关论文
共 96 条
  • [91] World Bank, 1993, WORLD DEV REP 1993 I, P329
  • [92] World Health Organization, 2006, Weekly Epidemiological Record, V81, P71
  • [93] World Health Organization, 1998, CONTR SURV AFR TRYP, P114
  • [94] The burden of malaria epidemics and cost-effectiveness of interventions in epidemic situations in Africa
    Worrall, E
    Rietveld, A
    Delacollette, C
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 71 (02) : 136 - 140
  • [95] The true burden and risk of cholera: implications for prevention and control
    Zuckerman, Jane N.
    Rombo, Lars
    Fisch, Alain
    [J]. LANCET INFECTIOUS DISEASES, 2007, 7 (08) : 521 - 530
  • [96] Drugs for neglected diseases
    Zumla, A
    [J]. LANCET INFECTIOUS DISEASES, 2002, 2 (07) : 393 - 393